Frontiers in Oncology | Breast Cancer

Original Research

Accepted on 14 Mar 2025

Differences in treatment response and survival between HER2(2+)/FISH-positive and HER2(3+) breast cancer patients after dual-target neoadjuvant therapy: a matched case-control study

in Breast Cancer

Sicheng Zhou
Xuhui Qin
Wei Xing
Zhao Xu
chunlv Wei
Yining Ren
Zixing Gong

Frontiers in Oncology

doi 10.3389/fonc.2025.1530793

Systematic Review

Accepted on 14 Mar 2025

Risk Factors for Breast Cancer Recurrence in Postmenopausal Women: A Bibliometric Study

in Breast Cancer

Teodora Hoinoiu
Daniel Pit
Cristina Oprean
Hoinoiu Bogdan
Andra DIACONESCU
Ljubisa Grujic
Luca Magda-Mihaela
DACIANA GRUJIC

Frontiers in Oncology

doi 10.3389/fonc.2025.1522713

Original Research

Published on 14 Mar 2025

Higher baseline platelet and preoperative platelets to lymphocytes ratio was associated with a higher incidence of axillary node pathologic complete response after neoadjuvant chemotherapy in HER2-low breast cancer: a retrospective cohort study

in Breast Cancer

Shuai Yang
Guanying Liang
Junyi Sun
Lingbing Yang
Zitong Fu
Wantong Sun
Bo Wei
Abiyasi Nanding
Qin Wang
Shouping Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1437677

133 views

Original Research

Published on 13 Mar 2025

Utilization of lymph node elastography in the axillary staging of breast cancer

in Breast Cancer

Marek Smolar
Eva Kudelova
Ivana Danova
Vincent Lucansky
Zuzana Dankova
Diana Musova
Marian Grendar
Lenka Nosakova
Peter Uhrik
Marek Samec

Frontiers in Oncology

doi 10.3389/fonc.2025.1478701

233 views

Original Research

Published on 13 Mar 2025

The evolving landscape of genetic biomarkers for immunotherapy in primary and metastatic breast cancer

in Breast Cancer

Liang Jin
Zijian Yang
Wei Tang
Pengli Yu
Rongrong Chen
Yan Xu
Jun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1522262

108 views

Case Report

Accepted on 12 Mar 2025

Symptomatic bone marrow metastasis in triple-negative breast cancer: a case report

in Breast Cancer

Chenhui Zheng
Jingjing Dai
Yu Wang
Danni Zheng
Renzhi Lin
Zhibao Zheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1570355

Original Research

Published on 12 Mar 2025

Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study

in Breast Cancer

Sara M. Tolaney
Komal Jhaveri
Teresa Helsten
Shannon L. Puhalla
Alison Conlin
E. Claire Dees
Muralidhar Beeram
Sonya C. Chapman
Andrew Lithio
Lacey M. Litchfield

Frontiers in Oncology

doi 10.3389/fonc.2025.1555921

305 views

Original Research

Published on 12 Mar 2025

Exploring pain management in breast cancer: key findings from the ARISE study

in Breast Cancer

Costanza M. Donati
Alice Zamagni
Arina A. Zamfir
Cynthia Aristei
Silvia Cammelli
Claudio Zamagni
Silvia Paolinelli
Milly Buwenge
Romina Rossi
Marco Maltoni

Frontiers in Oncology

doi 10.3389/fonc.2025.1536709

150 views

Opinion

Accepted on 11 Mar 2025

Redefining Conservative Mastectomy: The Evolution of Surgical Techniques

in Breast Cancer

Lorenzo Scardina
Gianluca Franceschini

Frontiers in Oncology

doi 10.3389/fonc.2025.1575095

Original Research

Published on 11 Mar 2025

Impact of wearing external breast prosthesis on body posture of patients after unilateral mastectomy: a randomized controlled trial

in Breast Cancer

HongMei Xie
XiaoQian Lan
YueHua Wang
QiuZhou Wang
Zi Ye
Hong Chen
Lan Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1456562

147 views

Original Research

Published on 11 Mar 2025

The value of intratumoral and peritumoral radiomics features based on multiparametric MRI for predicting molecular staging of breast cancer

in Breast Cancer

Yuxuan Han
Manxia Huang
Lizhi Xie
Yuhai Cao
Yang Dong

Frontiers in Oncology

doi 10.3389/fonc.2025.1379048

138 views

Study Protocol

Published on 11 Mar 2025

Efficacy of thunder-fire moxibustion for cancer-related fatigue in breast cancer survivors: study protocol for a randomized controlled trial

in Breast Cancer

Huakang Li
Zhonglin Zhang
Qiang Li
Yuyang Jin
Yunjing Jia
Pengxuan Gu
Qi Xiao
Lingna Jin
Ziliang Wu
Bing Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1496741

353 views

Original Research

Accepted on 10 Mar 2025

Abemaciclib Treatment Patterns and Outcome in HR+/HER2-Locally Advanced or Metastatic Breast Cancer: A Real-World Study from Kuwait and Lebanon

in Breast Cancer

Faisal Al Terkait
Anwar Al-Nouri
Hady Ghanem
Joseph Gergi Kattan
Nagi S El Saghir
Cynthia Bishouti
Soniya Rai
Alexandru Rosca

Frontiers in Oncology

doi 10.3389/fonc.2025.1437380

Original Research

Accepted on 10 Mar 2025

Predictive Model Using Systemic Inflammation Markers to Assess Neoadjuvant Chemotherapy Efficacy in Breast Cancer

in Breast Cancer

Yulu Sun
Yinan Guan
Hao Yu
Yin Zhang
Jinqiu Tao
Weijie Zhang
Yongzhong Yao

Frontiers in Oncology

doi 10.3389/fonc.2025.1552802

Review

Published on 10 Mar 2025

Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review

in Breast Cancer

Nadia Harbeck
Adam Brufsky
Chloe Grace Rose
Beata Korytowsky
Connie Chen
Krista Tantakoun
Endri Jazexhi
Do Hoang Vien Nguyen
Meaghan Bartlett
Imtiaz A. Samjoo

Frontiers in Oncology

doi 10.3389/fonc.2025.1530391

347 views

Original Research

Published on 10 Mar 2025

Clinical outcomes and aesthetic results of reverse sequence endoscopic versus traditional bilateral nipple-sparing mastectomy with immediate implant-based breast reconstruction-an analysis of initial 116 patients from single institution

in Breast Cancer

Qing Zhang
Faqing Liang
Juan Li
Yanyan Xie
Yu Feng
Mengxue Qiu
Jiao Zhou
Huanzuo Yang
Qing Lv
Zheng-gui Du

Frontiers in Oncology

doi 10.3389/fonc.2025.1496592

121 views

Navigation group

Articles

Differences in treatment response and survival between HER2(2+)/FISH-positive and HER2(3+) breast cancer patients after dual-target neoadjuvant therapy: a matched case-control study

Risk Factors for Breast Cancer Recurrence in Postmenopausal Women: A Bibliometric Study

Higher baseline platelet and preoperative platelets to lymphocytes ratio was associated with a higher incidence of axillary node pathologic complete response after neoadjuvant chemotherapy in HER2-low breast cancer: a retrospective cohort study

Utilization of lymph node elastography in the axillary staging of breast cancer

The evolving landscape of genetic biomarkers for immunotherapy in primary and metastatic breast cancer

Symptomatic bone marrow metastasis in triple-negative breast cancer: a case report

Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study

Exploring pain management in breast cancer: key findings from the ARISE study

Redefining Conservative Mastectomy: The Evolution of Surgical Techniques

Impact of wearing external breast prosthesis on body posture of patients after unilateral mastectomy: a randomized controlled trial

The value of intratumoral and peritumoral radiomics features based on multiparametric MRI for predicting molecular staging of breast cancer

Efficacy of thunder-fire moxibustion for cancer-related fatigue in breast cancer survivors: study protocol for a randomized controlled trial

Abemaciclib Treatment Patterns and Outcome in HR+/HER2-Locally Advanced or Metastatic Breast Cancer: A Real-World Study from Kuwait and Lebanon

Predictive Model Using Systemic Inflammation Markers to Assess Neoadjuvant Chemotherapy Efficacy in Breast Cancer

Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review

Clinical outcomes and aesthetic results of reverse sequence endoscopic versus traditional bilateral nipple-sparing mastectomy with immediate implant-based breast reconstruction-an analysis of initial 116 patients from single institution